Vraylar 1.5 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FMK2H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,200
Award facts
- Contract value 100% obligated
- $25,200.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $25,200.11 by the Defense Logistics Agency (DLA) on January 12, 2026, for the supply of Vraylar 1.5 mg capsules (30-count packages). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 13, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), which holds the parent Indefinite Delivery Contract with DLA. The company supplies a diverse portfolio of pharmaceutical products and medical supplies to support military healthcare systems worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. Vraylar, a neurological treatment medication, is among the company's specialized pharmaceutical offerings to federal medical procurement. The delivery order demonstrates AmerisourceBergen's continued capability to fulfill federal medical supply requirements through competitive procurement processes.
Quick answers
Who was awarded contract SPE2DR26FMK2H?
SPE2DR26FMK2H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FMK2H worth?
The government has obligated $25,200 on SPE2DR26FMK2H.
Is contract SPE2DR26FMK2H an order under another contract?
Yes. SPE2DR26FMK2H is a delivery order under SPE2DR25D1200, an indefinite delivery contract.
Was contract SPE2DR26FMK2H competed?
The extent of competition for SPE2DR26FMK2H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award